Plant-Based Diet Quality and Gastric Cancer Risk: A Case-Control Study in High-Risk Regions of Fujian Province, China.
환자-대조
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
672 participants (56.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Greater adherence to overall and healthy plant-based diet patterns was associated with a lower risk of GC, whereas higher adherence to unhealthy plant-based patterns was associated with a higher risk. These findings suggest that promoting higher-quality plant-based eating habits may be beneficial for GC prevention, particularly in high-risk populations.
Plant-based diets have been increasingly associated with cancer prevention, but the distinct impacts of healthy and unhealthy plant-based foods on gastric cancer (GC) risk remain uncertain.
- 95% CI 0.35-0.84
- OR 0.55
- 연구 설계 case-control
APA
Chen X, Wang Q, et al. (2026). Plant-Based Diet Quality and Gastric Cancer Risk: A Case-Control Study in High-Risk Regions of Fujian Province, China.. Food science & nutrition, 14(4), e71756. https://doi.org/10.1002/fsn3.71756
MLA
Chen X, et al.. "Plant-Based Diet Quality and Gastric Cancer Risk: A Case-Control Study in High-Risk Regions of Fujian Province, China.." Food science & nutrition, vol. 14, no. 4, 2026, pp. e71756.
PMID
41982493 ↗
Abstract 한글 요약
Plant-based diets have been increasingly associated with cancer prevention, but the distinct impacts of healthy and unhealthy plant-based foods on gastric cancer (GC) risk remain uncertain. This study aimed to investigate the associations of the overall plant-based dietary index (PDI), the healthy PDI (hPDI), and the unhealthy PDI (uPDI) with GC risk. A sex-matched case-control study was carried out in Fujian, China, between July 2023 and November 2024, including 336 newly diagnosed GC patients and 336 community controls. Dietary intake was evaluated using a validated food frequency questionnaire. In total, 672 participants (56.5% male) were analyzed, with cases being older than controls (mean age 56.76 vs. 53.86 years, < 0.001). Higher PDI was associated with a lower risk of GC (Q4 vs. Q1: OR = 0.55, 95% CI: 0.35-0.84, for trend = 0.001). For hPDI, the highest versus lowest quartile comparison suggested an inverse association (OR = 0.63, 95% CI: 0.41-0.96), although the trend test was marginally significant ( for trend = 0.069). Each 1-SD increase in PDI was associated with a 26% lower risk of GC (OR = 0.74, 95% CI: 0.63-0.87, < 0.001). Conversely, higher uPDI was associated with a markedly increased risk (OR = 2.42, 95% CI: 1.55-3.78, for trend < 0.001), with each 1-SD increase associated with a 56% higher odds of GC (OR = 1.56, 95% CI: 1.33-1.85, < 0.001). Subgroup analyses suggested that the inverse associations of PDI and hPDI with GC risk were more pronounced among smokers and individuals reporting low life stress, while the positive association of uPDI with GC risk appeared stronger in younger and married participants. Greater adherence to overall and healthy plant-based diet patterns was associated with a lower risk of GC, whereas higher adherence to unhealthy plant-based patterns was associated with a higher risk. These findings suggest that promoting higher-quality plant-based eating habits may be beneficial for GC prevention, particularly in high-risk populations.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Rare fusion transcript in a refractory adult T-cell lymphoblastic lymphoma.
- Rabdosin B suppresses proliferation of nonsmall cell lung cancer by regulating the SRC/PI3K/AKT signaling pathway.
- Development of a chemiluminescence immunoassay for proGRP in human serum.
- Genetically encoded biosensors in microbes for Tumor targeting.
- Analysis of discordant results in multi-technique platform-based MRD detection in multiple myeloma and the clinical decision-making dilemma.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Association of preoperative frailty and prognostic nutritional index with postoperative delirium in elderly gastric cancer patients: A single-center observational study.
- Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.
- Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K/Akt signaling pathway-mediated ferroptosis.
- Correction: Survival disparities and predictors in gastric cancer: a population-based study from Kazakhstan (2012-2023).